Drug Type Small molecule drug |
Synonyms Propiverine, Propiverine Hydeochloride, Propiverine hydrochloride (JP17) + [10] |
Target |
Action antagonists |
Mechanism mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (02 Apr 1993), |
Regulation- |
Molecular FormulaC23H30ClNO3 |
InChIKeyKFUJMHHNLGCTIJ-UHFFFAOYSA-N |
CAS Registry54556-98-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01007 | Propiverine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neurogenic detrusor overactivity | Canada | 05 Jan 2017 | |
Urinary Bladder, Overactive | Canada | 05 Jan 2017 | |
Urinary Incontinence | Japan | 02 Apr 1993 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urinary Incontinence, Urge | Phase 3 | China | 01 Jan 2010 | |
Urinary Bladder, Neurogenic | Phase 3 | Austria | 01 Dec 2004 | |
Urinary Bladder, Neurogenic | Phase 3 | Germany | 01 Dec 2004 | |
Urinary Bladder, Neurogenic | Phase 3 | Romania | 01 Dec 2004 | |
Klinefelter Syndrome | Phase 2 | - | 01 Oct 2004 |
Phase 4 | 649 | (Mirabegron + Solifenacin) | iaauqjzwpk = hpqcasfjwg zjxxpvuqwo (ekpnflaeyg, pjaolyrrwr - xecumxhmgf) View more | - | 24 Dec 2018 | ||
(Mirabegron + Propiverine) | iaauqjzwpk = dqxrotcsov zjxxpvuqwo (ekpnflaeyg, sdpzismpro - ficowsxbfq) View more | ||||||
Phase 3 | 324 | sgchehdiia(mkefiamsxd) = msdhjrbyda vboppzrvua (lmtjdlbxbj, 4.1) View more | Non-inferior | 01 Jan 2017 | |||
sgchehdiia(mkefiamsxd) = qsjdhccrci vboppzrvua (lmtjdlbxbj, 5.1) View more | |||||||
Phase 4 | 264 | dntowoaeis(xxetvgcngo) = vblloskdtc iyegyhyiga (nsvntorlea ) | Positive | 01 Jun 2010 | |||
Placebo | dntowoaeis(xxetvgcngo) = yakwhucspv iyegyhyiga (nsvntorlea ) | ||||||
Phase 2 | 25 | rwwoxsesmd(mfgvkypiza) = Most of the adverse events that were probably or possibly drug related were reported for patients in the high-dose group (>0.45 mg/kg) wzdgcwwlno (lsbugdycph ) | - | 01 May 2010 | |||
Phase 3 | 171 | jgctekfvfp(wwtcpawhmr) = iorubhjdiu rsdrweffsr (ezpcqzrbwk ) View more | Positive | 01 Mar 2009 | |||
Placebo | jgctekfvfp(wwtcpawhmr) = zhsndddbzu rsdrweffsr (ezpcqzrbwk ) View more |